How I Do It Afferent Loop Obstruction (ALO) With Hyper-Amylasemia And Deranged Liver Function Test, Are We Going To See This Complication More Frequently Again?

Main Article Content

M Al-Ardah
D Shetty
I Finlay

Abstract

Afferent loop syndrome is a known complication of gastric surgery, specifically after Billroth  II  and to a lesser extent a  Roux–en–Y reconstruction. However, the incidence decreased over the years proportionally with the decrease in the number of gastric surgeries.
Afferent loop syndrome can be either acute or chronic, with different presentations and treatment options. The acute type can occur early postoperatively or it could be a delayed presentation. Acute ALS is associated with complete closed-loop obstruction and is considered a surgical emergency, whereas chronic ALS is mostly related to partial obstruction of the afferent loop.
This rare complication can occur after the single anastomosis gastric bypass (Omega loop bypass) as it is a type of Billroth II reconstruction of gastric pouch–jejunostomy.
With the increase in the number of SAGB performed all over the world as weight reduction surgery for morbidly obese patient s surgeons should be aware of this complication and the treatment options. 


 

Downloads

Download data is not yet available.

Article Details

How to Cite
Al-Ardah, M. ., Shetty, D., & Finlay, I. (2023). How I Do It Afferent Loop Obstruction (ALO) With Hyper-Amylasemia And Deranged Liver Function Test, Are We Going To See This Complication More Frequently Again?. British Journal Of Surgical Science, 5(1). https://doi.org/10.54323/bjoss.2024.36
Section
UPPER GI

References

Bolckmans R, Arman G, Himpens J. Efficiency and risks of laparoscopic conversion of omega anastomosis gastric bypass to Roux-en-Y gastric bypass. Surgical Endoscopy. 2019;33:2572-82.

Jedamzik J, Bichler C, Felsenreich DM, Gensthaler L, Eichelter J, Nixdorf L, et al. Conversion from one-anastomosis gastric bypass to Roux-en-Y gastric bypass: when and why—a single-center experience of all consecutive OAGB procedures. Surgery for Obesity and Related Diseases.2022;18(2):225-32.

Kansou G, Lechaux D, Delarue J, Badic B, Le Gall M, Guillerm S, et al. Laparoscopic sleeve gastrectomy versus laparoscopic mini gastric bypass: one year outcomes. International Journal Of Surgery.2016;33:18-22.

Kular K, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrec-tomy and mini gastric bypass: a report from the Indian sub-continent. Obesity surgery. 2014;24:1724-8.

Lee WJ, Ser KH, Lee YC, Tsou JJ, Chen SC, Chen JC. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obesity surgery. 2012;22:1827-34.

Kassir R, Blanc P, Lointier P, Breton C, Debs T, Tiffet O. Laparoscopic revision of an omega loop gastric bypass to treat afferent loop syndrome. Obesity surgery. 2015;25:1976-8.

Roux G, Pedoussaut R, Marchal G. Afferent loop syndrome of gastrectomized subjects. Lyon chirurgical. 1950;45(7):773-80.

Ramos-Andrade D, Andrade L, Ruivo C, Portilha MA, Caseiro-Alves F, Curvo-Semedo L. Imaging the postoperative patient: long-term complications of gastrointestinal surgery. Insights into Imaging. 2016;7(1):7-20.

Landreneau JP, Barajas-Gamboa JS, Strong AT, Corcelles R, Kroh MD. Conversion of one-anastomosis gastric bypass to Roux-en-Y gastric bypass: short-term results from a tertiary referral center. Surgery for Obesity and Related Diseases. 2019;15(11):1896-902.

Chevallier JM, Arman GA, Guenzi M, Rau C, Bruzzi M, Beaupel N, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obesity surgery. 2015;25:951-8.

Poghosyan T, Caille C, Moszkowicz D, Hanachi M, Carette C, Bouillot JL. Roux-en-Y gastric bypass for the treatment of severe complications after omega-loop gastric bypass. Surgery for Obesity and Related Diseases. 2017;13(6):988-94.